ALEC

MKT CAP:$230M

Alector Inc

Market Cap

$230M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.64+$0.10 (+6.86%)

Jun 5, 2026

52W High $3.3252W Low $1.14

Company Details

Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody f...

CEO

—

IPO Date

Feb 7, 2019

Website

www.alector.com

Key Metrics TTM

Revenue

$18M

-79.2% YoY

Net Income

-$125M

EPS (Diluted)

Free Cash Flow

-$173M

Revenue / Share

$0.17

Gross Margin

88.7%

Operating Margin

-741.3%

Net Margin

-680.8%

FCF Margin

-940.4%

P/S

12.5x

P/E

Earnings Reports

Q2 2026

Aug 10, 2026

PENDING

Q1 2026

May 7, 2026

$1M-71.5%

FY 2025

Feb 25, 2026

$21M-79.1%

Q4 2025

Feb 25, 2026

$6M-88.5%

Q3 2025

Nov 6, 2025

$3M-78.8%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee